Transcriptomics profiles in intestinal sulfide overproduction, small intestinal bacterial overgrowth, and intestinal methanogen overgrowth
Open Access
- 29 June 2026
- journal article
- Published by American Society for Microbiology in mSystems
- Vol. 11 (7) , e0045826
Abstract
Despite advances in identifying distinct microbial profiles linked to intestinal sulfide overproduction (ISO), small intestinal bacterial overgrowth (SIBO), and intestinal methanogen overgrowth (IMO), differences in host small bowel (SB) gene expression remain unexplored. Therefore, we compared host gene transcriptomics in SB biopsies from subjects with IMO, ISO, and SIBO. Separately, SB transcriptomics in rats gavaged with hydrogen sulfide (H 2 S) producers were also analyzed. ISO subjects exhibited unique transcriptomics profiles. ISO (≥1.5 parts per million [ppm] H 2 S) broadly affected genes linked to H₂S toxicity, such as electron transport chain and redox balance genes, while there were fewer significant effects on gene expression in IMO and SIBO. Rat data supported ISO findings, including dysregulation of mitochondrial respiration, redox balance, water homeostasis, immune response, and gut motility. IMPORTANCE: Intestinal sulfide overproduction (ISO), intestinal methanogen overgrowth (IMO), and small intestinal bacterial overgrowth (SIBO) are conditions associated with higher levels of breath hydrogen sulfide and methane, respectively, and higher bacterial colony counts on small bowel aspirate cultures. While these conditions correlate with gastrointestinal symptoms, the cellular mechanisms involved when analyzed either separately or concomitantly are not well understood. Here, we aimed to explore changes in human small bowel transcriptomics in ISO, IMO, and/or SIBO, and to investigate if changes in ISO reflect those seen in models of rats gavaged with known hydrogen sulfide producers. The results demonstrate that each condition is unique and has its own transcriptomics profile, with ISO showing a greater effect on the host, which was partially validated by transcriptomic analyses in the small bowel of rats gavaged with hydrogen sulfide-producing bacteria. This study supports the need for individualized therapeutic strategies for each condition in the future.Keywords
Funding Information
- Scott Gray Foundation
- Steve Perry Foundation
- Monica Lester Charitable Trust
- Elia, Genevieve, and Georgianna Atol Charitable Trust
This publication has 93 references indexed in Scilit:
- Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and MethanogensDigestive Diseases and Sciences, 2025
- Visualizing set relationships: EVenn's comprehensive approach to Venn diagramsiMeta, 2024
- Hydrogen Sulfide Producers Drive a Diarrhea-Like Phenotype and a Methane Producer Drives a Constipation-Like Phenotype in Animal ModelsDigestive Diseases and Sciences, 2023
- The serotonin receptor 3E variant is a risk factor for female IBS-DJournal of Molecular Medicine, 2022
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapyProtein & Cell, 2020
- Microbiome and Its Role in Irritable Bowel SyndromeDigestive Diseases and Sciences, 2020
- The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel SyndromeDigestive Diseases and Sciences, 2012
- Methane on Breath Testing Is Associated with Constipation: A Systematic Review and Meta-analysisDigestive Diseases and Sciences, 2011
- Tachykinins and their functions in the gastrointestinal tractCellular and Molecular Life Sciences, 2007